Metraipolis › archive › dc_b084fcab8401
High-Throughput Transcriptomics of Nontumorigenic Breast Cells Exposed to Environmentally Relevant Chemicals — Europe PMC PMID:38568856
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/38568856
- DOI
- 10.1289/ehp12886
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-06T20:05:41.856Z
- SHA-256 of the archived text
7511c1d1162e62361718d264be90a5756b18f3e9d7b70456a447e95361b33854- Stable URL of this page
https://metraipolis.com/documento/dc_b084fcab8401
How to cite
High-Throughput Transcriptomics of Nontumorigenic Breast Cells Exposed to Environmentally Relevant Chemicals — Europe PMC PMID:38568856 — Europe PMC (en), https://europepmc.org/article/MED/38568856 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_b084fcab8401 (Metraipolis archive dc_b084fcab8401, sha256 7511c1d1162e62361718d264be90a5756b18f3e9d7b70456a447e95361b33854)
BibTeX
@misc{dcb084fcab8401,
title = {High-Throughput Transcriptomics of Nontumorigenic Breast Cells Exposed to Environmentally Relevant Chemicals — Europe PMC PMID:38568856},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/38568856},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_b084fcab8401; sha256 7511c1d1162e62361718d264be90a5756b18f3e9d7b70456a447e95361b33854},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/38568856. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: There is a suite of chemicals, including metals, pesticides, and personal care product compounds, which are commonly detected at high levels in US Center for Disease Control's National Health and Nutrition Examination Survey (NHANES) chemical biomarker screens. Whether these chemicals influence development of breast cancer is not well understood. Objectives: The objectives were to perform an unbiased concentration-dependent assessment of these chemicals, to quantify differences in cancer-specific genes and pathways, to describe if these differences occur at human population-relevant concentrations, and to specifically test for differences in markers of stemness and cellular plasticity. Methods: We treated nontumorigenic mammary epithelial cells, MCF10A, with 21 chemicals at four concentrations (25 nM, 250 nM, 2.5μM, and 25μM) for 48 h. We conducted RNA-sequencing for these 408 samples, adapting the plexWell plate-based RNA-sequencing method to analyze differences in gene expression. We calculated gene and biological pathway-specific benchmark concentrations (BMCs) using BMDExpress3, identifying differentially expressed genes and generating the best fit benchmark concentration models for each chemical across all genes. We identified enriched biological processes and pathways for each chemical and tested whether chemical exposures change predicted cell type distributions. We contextualized benchmark concentrations relative to human population biomarker concentrations in NHANES. Results: We detected chemical concentration-dependent differences in gene expression for thousands of genes. Enrichment and cell type distribution analyses showed benchmark concentration responses correlated with differences in breast cancer-related pathways, including induction of basal-like characteristics for some chemicals, including arsenic, lead, copper, and methyl paraben. Comparison of benchmark data to NHANES chemical biomarker (urine or blood) concentrations indicated an overlap between exposure levels and levels sufficient to cause a gene expression response. Discussion: These analyses revealed that many of these 21 chemicals resulted in differences in genes and pathways involved in breast cancer in vitro at human exposure-relevant concentrations. https://doi.org/10.1289/EHP12886. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: Environmental health perspectives, 2024 (prima pubblicazione 2024-04-03). Identificativi: PMID 38568856 · PMCID PMC10990114 · DOI 10.1289/ehp12886. Descrittori MeSH principali: Breast Neoplasms; Gene Expression Profiling. Pagina: https://europepmc.org/article/MED/38568856 — https://doi.org/10.1289/ehp12886. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-06T18:30:56.353Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.